Login
Red Book 5th Edition' Membership 2016' ELSO Discussion Board' 28th Annual Conference' 2017 SEECMO' 2017 June Philadelphia Adult ECMO' 2017 APELSO Meeting' 2017 APELSO Adult Course Hong-Kong'

Welcome to ELSO!

 

What is ELSO?

The Extracorporeal Life Support Organization (ELSO) is an international non-profit consortium of health care centers and individuals who are dedicated to the development, evaluation and improvement of extracorporeal membrane oxygenation (ECMO) and other innovative therapies for support of failing organ systems in the neonate, child and adult. ELSO is made up of a broad multidisciplinary collaboration of physicians, nurses, perfusionists, respiratory therapists, technicians, researchers, and industry experts. Global chapters of ELSO provide education and expertise in ECMO delivery around the world.

How Does ELSO Accomplish Its Mission?

ELSO serves the needs of patients and the extracorporeal support community through:

-Maintaining, since 1989, the world’s largest registry of data on patients receiving ECMO

-Using ELSO registry data to support clinical research, individual ELSO center quality assessment, and regulatory needs for ECMO

-Providing state-of-the art ECMO educational programs including expert didactics and hands-on simulation training around the globe

-Publishing the ELSO Red Book, the the definitive reference of physiology and clinical provision of ECMO

-Partnering with its global chapters (EuroELSO, Asia-Pacific ELSO, Latin American ELSO, and South and West Asia ELSO) to advance ECMO support internationally

-Hosting the annual ELSO Educational and Scientific Conference, in addition to supporting global chapter conferences

-Benchmarking delivery of institutional ECMO support through the ELSO Award of Excellence for centers (recognized by US News and World Report)

-Advocating for technological and industry-based improvement in ECMO delivery and devices

 

Visit around this website for all things ECMO and ECLS.
Notice:

Data Entry Deadline for July Reports:

All forms must be submitted by July 9th, 2017 in order to be included in the July reports.

 

The Red Book 5th Edition now available!!  

www.elso.org/Publications/RedBook5thEdition.aspx

 

The ELSO May 2017 Newsletter is now available.  You must be logged in to download.

 

  

 

 

ECMO Research

Predictors of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation: an observational cohort study.
Author: Fletcher Sandersjöö A, Bartek J, Thelin EP, Eriksson A, Elmi-Terander A, Broman M, Bellander BM
Predictors of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation: an observational cohort study. J Intensive Care. 2017;5:27 Authors: Fletcher Sandersjöö A, Bartek J, Thelin EP, Eriksson A, Elmi-Terander A, Broman M, Bellander BM Abstract ...

Adjunct Therapies for Refractory Status Asthmaticus in Children.
Author: Rehder KJ
Adjunct Therapies for Refractory Status Asthmaticus in Children. Respir Care. 2017 Jun;62(6):849-865 Authors: Rehder KJ Abstract Asthma exacerbation is a common reason for children to present to the emergency department. If primary therapies fail to halt the progression...

Extracorporeal Membrane Oxygenation for Severe Pediatric Respiratory Failure.
Author: Lin JC
Extracorporeal Membrane Oxygenation for Severe Pediatric Respiratory Failure. Respir Care. 2017 Jun;62(6):732-750 Authors: Lin JC Abstract Extracorporeal membrane oxygenation (ECMO) was developed initially in the 1960s to support refractory respiratory failure in...

Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in Adults.
Author: St-Onge M, Anseeuw K, Cantrell FL, Gilchrist IC, Hantson P, Bailey B, Lavergne V, Gosselin S, Kerns W, Laliberté M, Lavonas EJ, Juurlink DN, Muscedere J, Yang CC, Sinuff T, Rieder M, Mégarbane B
Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in Adults. Crit Care Med. 2017 Mar;45(3):e306-e315 Authors: St-Onge M, Anseeuw K, Cantrell FL, Gilchrist IC, Hantson P, Bailey B, Lavergne V, Gosselin S, Kerns W, Laliberté M, Lavonas EJ,...
Regulatory: Device Recalls

EBI Patient Care, Inc. - SpFPLUS Implantable Stimulator - Class 1 Recall
10-1398M - SpF-PLUS Implantable Stimulator. Indicated as a spinal fusion adjunct to increase the probability of fusion success in 1 or 2 levels.

EBI Patient Care, Inc. - SpFXL IIB 2/DM Implantable Stimulator - Class 1 Recall
10-1335M - SpF-XL IIB 2/DM Implantable Stimulator. Indicated as a spinal fusion adjunct to increase the probability of fusion success in 1 or 2 levels.

Thoratec Corporation - HeartMate II Left Ventricular Assist System (LVAS) with Pocket Controller - Class 1 Recall
HeartMate¿ II LVAS with Pocket Controller; 107801 - HMII PUMP & POCKET CTRL ONLY UDI:00813024011286 Intended to provide hemodynamic support in patients with end-stage, refractory left ventricular heart failure; intended for use inside or outside the hospital.

Thoratec Corporation - HeartMate II Left Ventricular Assist System (LVAS) with Pocket Controller - Class 1 Recall
HeartMate¿ II LVAS with Pocket Controller; 106762 - HMII POCKET CONTROLLER, NA; UDI: 00813024011286 Intended to provide hemodynamic support in patients with end-stage, refractory left ventricular heart failure; intended for use inside or outside the hospital.

Thoratec Corporation - HeartMate II Left Ventricular Assist System (LVAS) with Pocket Controller - Class 1 Recall
HeartMate¿ II LVAS with Pocket Controller; 106015 - HMII LVAD SEALED KIT-PCTRL, NA UDI: 00813024011224 Intended to provide hemodynamic support in patients with end-stage, refractory left ventricular heart failure; intended for use inside or outside the hospital.

Magellan Diagnostics, Inc. - LeadCare Plus Blood Lead Testing System - Class 1 Recall
Magellan Diagnostics LeadCare Ultra Blood Lead Test Kits Part Number: 80-0010
< >